Apogee Therapeutics, Inc. Common Stock (APGE) Sentiment
30-day SentiSense Score 0.54 · Neutral · ▲ warming · as of 2026-09-07
APGE sentiment is neutral (30-day SentiSense Score 1) and strengthening from a month ago; there is no reading for today yet. Attention averages ~6 mentions/day (2 today).
- Sentiment (30-day)
- Neutral
- SentiSense Score (30-day avg)
- 0.54
- Mentions / day (30-day avg)
- 6 (2 today)
Where the conversation is happening
- News
- Bullish · 76% of mentions
- X
- Bullish · 24% of mentions
Related tickers
What's driving it
- AbbVie closes its $10.9 billion Apogee Therapeutics acquisition, adding a late-stage immunology pipeline (+0.08)
- AbbVie Acquires Apogee Therapeutics for $10.9 Billion in Cash (+0.38)
- AbbVie Acquires Apogee Therapeutics for $10.9 Billion (+0.41)
Live SentiSense Score, sentiment history, and per-source breakdown for Apogee Therapeutics, Inc. Common Stock on SentiSense.
See how APGE's sector compares in the market sentiment heatmap